Metoclopramide Hydrochloride Injection Completed Acceptance

On November 7, 2023, the company's metoclopramide hydrochloride injection was accepted by the State Food and Drug Administration.Metoclopramide Hydrochloride Injection is a gastrointestinal motility enhancer and is often used clinically as an antiemetic... 


About Genchain

 

             Brand introduction

             Corporate culture

 

     Product portfolio

 

           Approved products

           Skin care

           Pediatric medicine    

           Chronic diseases

 

                   News

 

                        Brand introduction

                        Corporate culture

                        First approval of NMPA

                        New filling

                        Central procurement result

 

Developmental strategy

 

    Development concept

    Intellectual property

    New field expansion

    Future plans

 

 

 Global Expansions 

 

          API registration and marketing

          Sales and marketing

          Product import and export

 

 

           ————————————————————————————————————————————————————————————————————————————————————————————————————

© 2023 Copyright Hainan Genchain Biotechnology Co., Ltd

Filing number

Add WeChat friend to learn more about the product
Use Enterprise WeChat
"Scan" to join the group chat
Copy success!
Add WeChat friend to learn more about the product
I see.